Physicians are accustomed to making decisions based on information regarding the prevalence of disease, symptoms, physical signs, laboratory test results, and the risks and bene®ts of alternative treatments. If nutritional assessment and therapeutics are to become more common components of medical practice, signi®cant barriers in each of these areas must be overcome. Even rudimentary dietary assessment is often missing from physician education. Dietary assessment tools that are readily available and that have demonstrated usefulness are largely unknown. In addition, many nutritional interventions have not been formally investigated in randomized, controlled trials, and thus their cost-effectiveness remains unknown. We present one approach to these issues by discussing the construction of a decision model examining strategies for vitamin D and calcium screening. The application of medical decision making techniques to problems in clinical nutrition illustrates how ®ndings from research studies may be used to determine the risks, bene®ts and costs of alternative population based health related nutrition policies which can then be applied by physicians in their daily interactions with patients.
Introduction
One of the primary roles of the physician is to make decisions (Pauker & Kassirer, 1981) . Physicians decide what questions to ask patients, what ®ndings they will look for on physical examination, what tests to order, and how to interpret these tests. Based on the results of these various evaluations, physicians, along with their patients, decide what therapeutic strategies to pursue. In order to make these decisions effectively, physicians need to understand how well the questions they ask, the maneuvers they carry out, and the tests they order perform in diagnosing or excluding various conditions. They also need to have a sense of how likely it is that a patient with a positive result has the condition in question and how likely a patient with a negative result is to be free of it. Finally, they need to be aware of the potential ef®cacies, costs, and adverse effects of various therapies in populations similar to those of the patient they wish to treat.
Physicians who wish to integrate nutritional evaluation and treatment into their practices often ®nd themselves illequipped to make this sort of diagnostic and treatment decision. Among health professionals, physicians are uniquely well prepared to identify patients at risk for diseases with well-established nutritional risk factors, to recognize aspects of the past medical history which may in¯uence nutritional function, and to detect and diagnose the myriad conditions which could potentially affect nutritional status. But medical undergraduate and post graduate training generally fails to address another area fundamental to effective nutritional assessment and intervention Ð dietary assessment (Ross, 1998) . Moreover few validated assessment tools exist for the physician's use in this area. In addition, many nutritional interventions have not been formally investigated in randomized, controlled trials performed in many populations of interest and thus their ef®cacies and costs are largely unknown.
The application of cost-effectiveness decision analytic techniques may help to address some of these problems. Such methods utilize computer simulations (Lau et al, 1983; Sonnenberg & Pauker, 1986) to model the natural history of a disease given various treatment strategies. They incorporate data from multiple sources, and enable investigators to estimate potential outcomes and costs associated with therapeutic strategies, even if these strategies have not yet been examined in randomized controlled trials. The metric resulting from the analysisÐ the marginal costeffectiveness ratio Ðoften expressed as the additional expenditure necessary to gain an additional year of life under a more expensive strategy compared to a less expensive strategy, is used to compare one strategy to another. In the discussion which follows, issues encountered in the construction of a model designed to examine strategies for vitamin D and calcium supplementation (Ross et al, 1997a,b) will be used to illustrate how application of techniques borrowed from the ®eld of medical decision making may help to overcome barriers physicians might encounter when attempting build nutrition interaction into their clinical practice.
The ®rst step in constructing a decision model is to identify the clinical problem to be addressed, the clinical strategies one wishes to examine, and the population of interest one wishes to examine them in (Sonnenberg & Beck, 1993) . Given the mortality (Kenzora et al, 1984; Elmerson et al, 1988; Magaziner et al, 1989; Fisher et al, 1991) , morbidity (Fitzgerald et al, 1987 (Fitzgerald et al, , 1988 Kiel et al, 1994) , and costs (Phillips et al, 1988; Chrischilles et al, 1994) associated with osteoporotic hip fracture, the experimental evidence for the use of vitamin D and calcium supplementation in the prevention of hip fracture in an elderly French population (Chapuy et al, 1992) , and the evidence about low calcium intakes (Alaimo et al, 1994) and poor vitamin D status (Dawson-Hughes, 1997) among post menopausal women in the USA, we chose to examine strategies for calcium and vitamin D supplementation in this latter group. We wished to examine three strategies for calcium and vitamin D supplementation: (1) universal supplementation with vitamin D (800IU) and calcium (1500 mgad), (2) no intervention, and (3) targeted supplementation. Under the targeted supplementation strategy, physicians would estimate their patient's calcium intakes and vitamin D status and then prescribe levels of supplementation based on this evaluation.
In explicitly outlining these strategies, it was necessary to identify a method by which physicians could easily evaluate calcium intake in their of®ces. A brief food frequency questionnaire (FFQ) could easily be administered in the primary care setting, but its test characteristics, including sensitivity (the percent of patients with actual low calcium intake that the FFQ would identify) and speci®city (the percent of patients with actual adequate calcium intake the questionnaire would identify) were unknown. In building the model, this information would be necessary in order to estimate the percentage of those screened who would require supplementation under the targeted supplementation strategy. In practice, physicians using this test would need this information in order to understand when to use it and how to interpret the results.
In order to estimate the test characteristics of the brief FFQ we identi®ed research from the published literature validating the brief food frequency questionnaire (FFQ) against the gold standard of the food record (Cummings et al, 1987; Angus et al, 1989; Musgrave et al, 1989; Brown & Griebler, 1993; Wilson & Horwath, 1996) . English language papers which compared these methods in women aged 45± 90 y (our population of interest), and which presented data in a manner which allowed the calculation of sensitivity and speci®city were included. Systat version 7.0 was used for calculations.
In Figure 1 , daily estimated calcium intakes of experimental subjects pooled from studies which met the above criteria are presented. Although correlations between these two methods were high at 0.78 (P`0.05), the sensitivity of the brief FFQ for detecting those with the lowest calcium intake (below 500 mg), was low at 55% while its speci®city was high at 92% (See Table 1 ).
These are no optimal test characteristics for a test designed to guide the use of a low-risk low-cost intervention. In the case of calcium supplementation,`missing' a woman with low intakes and failing to offer her supplementation is probably worse than advising a woman with adequate intakes to use supplements, because supplementing an individual in excess of her needs might carry a small risk of renal stones, but failing to supplement an individual with low intakes might place her at risk for the more serious outcome of osteoporotic fracture. A more useful clinical test in this setting would be highly sensitive, even at the expense of speci®city. To create such a test, more diet items could be added to the brief food frequency Figure 1 In the graphs above, calcium intakes determined by food records are plotted on the y axes and those estimated by brief FFQ on the x axes. A standard brief FFQ is represented in the left hand graph, and a`Super-sensitive' FFQ (see text) in the right hand graph. Dotted lines divide the graphs into four areas. The boxes in the lower left hand corners, marked`TP' for`true positives' contains instances in which the brief FFQs correctly identi®ed subjects with calcium intakes lower than 500 mg. The box in the upper left hand corners, marked`FP' for`false positives' contains instances in which the brief FFQs identi®ed subjects as having intakes below 500 mg, when their actual intake was in excess of that amount. The boxes in the upper right hand corners, marked`TN' for`true negatives' contains instances in which the brief FFQs correctly identi®ed subjects as having intakes above 500 mg. The boxes in the lower right hand corners, marked`FN' for`false negatives' identi®es instances in which the brief FFQs identi®ed subjects as having intakes over 500 mg when their actual intakes were below those amounts. Note the absence of false negatives in the right hand graph.
questionnaire, but this would decrease the ease and increase the costs of administering such an instrument. Alternatively, intakes calculated by the existing brief FFQ could be adjusted downwards by subtracting a correction factor from the estimated intake values. The sensitivities and speci®-cities of such a`super-sensitive' FFQ, in which estimated values are corrected downwards by 250 mg, which are more desirable for the problem at hand, are presented in Table 2 .
After identi®cation of the clinical problem, strategies, and the population of interest, the next step in the construction of the decision model is to identify`states of health' (Sonnenberg & Beck, 1993) . These`states of health' are chosen to re¯ect aspects of the natural history of disease representing unique outcomes and costs. In our hip fracture model, for example, it was important to include states of health representing both patients discharged to home and patients discharged to a nursing home following fracture, since these two dispositions are associated with very different qualities of life and cost. States of health in a simpli®ed hip fracture model are represented by the ellipses in Figure 2 .
Once the states of health have been identi®ed, the next step is to identify`transition probabilities' (Sonnenberg & Beck, 1993) or the probabilities of moving from one state to another. Examples of these transitions, such as the probability of having a hip fracture, dying of a hip fracture, dying of other causes, etc, are indicated by arrows in Figure  2 . These probabilities are based on randomized controlled trials, epidemiological studies, census data, population surveys and other published sources. In the event that no published data is available on which to base estimates, unpublished data or expert opinion is solicited.
One powerful aspect of this type of modeling technique is that it allows the results of randomized trials performed in one population to be generalized to other populations of interest. In our model, for example, we wanted to base estimates of the ef®cacy of vitamin D and calcium supplementation on a randomized controlled trial performed in very elderly institutionalized French women (Chapuy et al, 1992) . The subjects in this trial were at very high risk vitamin D de®ciency due to their advanced age, lack of sun exposure, and lack of dietary forti®cation with vitamin D in France. Our population of interest, on the other hand, was at lower risk due to their younger age, greater degree of sun exposure, and forti®cation in the United States. It is unlikely that these two populations, therefore, would experience identical reductions in fracture rates with supplementation, and to apply risk reductions seen in the French women to our population of interest overall might bias our results considerably. In order to assess this problem, we determined transition probabilities for hip fracture as follows. We ®rst determined probabilities of hip fracture by age using data from epidemiological studies performed in the United States (Gallagher et al, 1980; Farmer et al, 1984; Petitti & Sidney, 1989; Kellie & Brody, 1990; Fisher et al, 1991) . Next, we strati®ed our population of interest by degree of subclinical vitamin D de®ciency (Dawson-Hughes, 1997). We then adjusted baseline probabilities of hip fracture for degree of vitamin D de®ciency using odds likelihood ratios based on data from a case-control study on vitamin D status in communitydwelling patients with and without hip fracture (Lips et al, 1987) . Finally, we applied the risk reductions observed in the clinical trial with supplementation (Chapuy et al, 1992) only to the segments of each cohort de®cient in vitamin D.
After assigning transition probabilities, the next step in the construction of the decision model is to de®ne the cycle length, or the frequency at which subjects can move from one state of health to another (Sonnenberg & Beck, 1993) , to add relevant cost data to the model, and to make quality of life adjustments (if desired). In our model a cycle length of one month was used in order to capture short periods of hospitalization and varying length of institutionalization following hip fracture, both of which are associated with unique costs. Cost data considered included a periodic cost of nutritional evaluation, costs of supplementation, treatment of hip fracture, and institutionalization. We performed the analysis with and without quality of life adjustments.
Finally, the analysis is performed. In the simulation, hypothetical cohorts of subjects, one for each strategy of interest, are tracked over their lifetimes. Each cycle, subjects move from one state of health to another based on transition probabilities. The simulation continues until all of the subjects are dead, or for a set amount of time. As subjects move through the model, they incur costs of screening, supplementation, hospitalization, and institutionalization, and accure credit for each month of life lived. If quality of life adjustments have been made, one month spent in a state of health associated with a lower than normal quality of life`counts' for less than one month of life. Finally, average life expectancies and costs are calculated for each strategy, and marginal cost effectiveness ratios of more expensive strategies compared to less expensive strategies are calculated and compared, and preferred strategies are determined.
The next step is to perform sensitivity analyses. In these analyses, the computer simulation is performed repeatedly, and inadequate calcium intake were to be`set' at the lowest end of their con®dence interval, the cost of supplementation were to be`set' at the highest end of its con®dence interval, and the ef®cacy of supplementation were to bè set' at the lowest end its con®dence interval,`no intervention' rather than`universal supplementation' might be the preferred strategy. Sensitivity analysis thus allows investigators to judge the robustness of their results, and physicians to have con®dence in these results when applying them in their clinical practices.
Conclusion
If physicians are to have an effective nutrition interaction with their patients, they need to have methods by which to assess relevant aspects of their patient's nutritional status, just as they have methods by which to assess cardiac and gastrointestinal status. Physicians also need to have a quantitative understanding of the ef®cacy and costs of nutritional interventions just as they do of medical and surgical interventions. Dietary assessment is an important aspect of this nutritional assessment, however physicians generally aren't taught dietary assessment in medical school, and very few good clinical tools exist for this purpose. Research tools might be adapted for clinical use, using methods similar to those demonstrated above for the brief food frequency questionnaire for calcium above. This should be with clinical goals, such as identifying patients who meet appropriate criteria for a particular nutritional therapy (for example), rather than research goals, such as exact quantitation of intake of a particular nutrient, clearly in mind. Test characteristics such as sensitivity and speci®city, etc, should be determined for nutritional assessment methods in order to support physician's capacities to make decisions based on their results in clinical practice. Finally, using decision analytic cost-effectiveness techniques, investigators may quantify the expected costs and outcomes associated with nutrition interventions, even if such interventions have not been formally studied in the population of interest. This quanti®cation, along with evidence of its robustness, may both convince physicians of the clinical worth of nutritional interventions (which many may view as having low ef®cacy compared to more standard medical and surgical interventions), and enhance their ability to discuss nutritional interventions with their patients.
